Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,594 shares at $425.70 ($1.1M) on 2024-02-26, disclosed to the SEC on 2024-02-27.
Scheduled sale ($1.1M) by SVP & Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $431.79 | 828 | $358K | 32.2% |
| 2 | $425.70 | 883 | $376K | 33.9% |
| 3 | $425.70 | 883 | $376K | 33.9% |
| Total | $427.64 avg | 2,594 | $1.1M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2026-02-12 | $634K | — | Filing → |
| VRTX | SELL | 2025-02-26 | $850K | — | Filing → |